About Liminatus Pharma Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: http://liminatuspharma.com/
Frequently Asked Questions
What is the 52-week range for LIMN?
The 52-week high is $141.5 and the 52-week low is $3.29.
What is the P/E ratio for LIMN?
The P/E ratio data is currently unavailable.
What is the dividend yield for LIMN?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
ROE data is currently unavailable.
What is the Net Profit Margin?
Net Margin data is currently unavailable.
What is the Price to Book (P/B) Ratio?
P/B ratio data is currently unavailable.
Latest LIMN News
Liminatus Pharma Regains Compliance with Nasdaq Minimum Bid Price Rule
FULLERTON, Calif., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (Nasdaq: LIMN) (“Liminatus” or the “Company”) today announced that the Company has regained compliance with Nasdaq’s minimum bid price rule. As previously disclosed, on January 15, 2026 the Company received a notice from Nasdaq indicating that the closing bid price of the Company’s common stock had been below $1.00 for 30 consecutive business days, and, consequently, the Company was not in compliance with Nasdaq Listing
Liminatus Pharma Regains Compliance With Nasdaq’s Minimum Bid Price Rule
On September 24, 2026, the Company received a notice from Nasdaq stating that, for the 13 consecutive trading days from August 21, 2026 to September 9, 2026, the closing bid price of the Company’s common stock had been
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-07-02 | Valetudo Therapeutics LLC | +3,448,926 | - | - |
| 2026-06-24 | Valetudo Therapeutics LLC | -4,373,603 | - | - |